Focal Scleral Nodule: A New Name for Solitary Idiopathic Choroiditis and Unifocal Helioid Choroiditis.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
11 2020
Historique:
received: 02 02 2020
revised: 09 04 2020
accepted: 15 04 2020
pubmed: 9 6 2020
medline: 23 12 2020
entrez: 9 6 2020
Statut: ppublish

Résumé

To evaluate multimodal imaging findings of solitary idiopathic choroiditis (SIC; also known as unifocal helioid choroiditis) to clarify its origin, anatomic location, and natural course. Multicenter retrospective observational case series. Sixty-three patients with SIC in 1 eye. Demographic and clinical data were collected. Multimodal imaging included color fundus photography, OCT (including swept-source OCT), OCT angiography (OCTA), fundus autofluorescence, fluorescein and indocyanine green angiography, and B-scan ultrasonography. Standardized grading of imaging features. Mean age at presentation was 56 ± 15 years (range, 12-83 years). Mean follow-up duration in 39 patients was 39 ± 55 months (range, 1 month-25 years). The lesions measured a mean of 2.4 × 2.1 mm in basal diameter, were located inferior (64%) or nasal to the optic disc, and appeared yellow (53%). No systemic associations were found. The lesions all appeared as an elevated subretinal mass, with OCT demonstrating all lesions to be confined to the sclera, not the choroid. On OCT, the deep lesion margin was visible in 12 eyes with a mean lesion thickness of 0.6 mm. Overlying choroidal thinning or absence was seen in 95% (mean choroidal thickness, 28 ± 35 μm). Mild subretinal fluid was observed overlying the lesions in 9 patients (14%). Retinal pigment epithelial disruption and overlying retinal thinning was observed in 56% and 57%, respectively. OCT angiography was performed in 13 eyes and demonstrated associated choroidal and lesional flow voids. Four lesions (6%) were identified at the macula, leading to visual loss in 1 patient. One lesion demonstrated growth and another lesion showed spontaneous resolution. In this largest series to date, multimodal imaging of SIC demonstrated a scleral location in all patients. The yellow and white clinical appearance may be related to scleral unmasking resulting from atrophy of overlying tissues. Additional associated features included documentation of deep margin on swept-source OCT, trace subretinal fluid in a few patients, and OCTA evidence of lesional flow voids. Because of the scleral location of this lesion in every patient, a new name, focal scleral nodule, is proposed.

Identifiants

pubmed: 32507351
pii: S0161-6420(20)30396-1
doi: 10.1016/j.ophtha.2020.04.018
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1567-1577

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Adrian T Fung (AT)

Westmead and Central (Save Sight Institute) Clinical Schools, Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, Australia; Department of Ophthalmology, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.

Sebastian M Waldstein (SM)

Westmead and Central (Save Sight Institute) Clinical Schools, Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, Australia; Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. Electronic address: sebastian.waldstein@meduniwien.ac.at.

Orly Gal-Or (O)

Vitreous Retina Macula Consultants of New York, New York, New York; Department of Ophthalmology, NYU School of Medicine, New York, New York; Rabin Medical Center, Petach Tikva, Israel.

Marco Pellegrini (M)

Eye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco", Luigi Sacco Hospital, University of Milan, Milan, Italy.

Chiara Preziosa (C)

Eye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco", Luigi Sacco Hospital, University of Milan, Milan, Italy.

Jerry A Shields (JA)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.

R Joel Welch (RJ)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.

Rosa Dolz-Marco (R)

Vitreous Retina Macula Consultants of New York, New York, New York; Department of Ophthalmology, NYU School of Medicine, New York, New York; Unit of Macula, Oftalvist Clinic, Valencia, Spain.

David Sarraf (D)

Stein Eye Institute, University of California, Los Angeles, Los Angeles, California; Greater Los Angeles VA Healthcare Center, Los Angeles, California.

Aaron Nagiel (A)

Stein Eye Institute, University of California, Los Angeles, Los Angeles, California; Greater Los Angeles VA Healthcare Center, Los Angeles, California.

Robert Lalane (R)

Stein Eye Institute, University of California, Los Angeles, Los Angeles, California; Greater Los Angeles VA Healthcare Center, Los Angeles, California.

Jesse J Jung (JJ)

East Bay Retina Consultants, Inc., Oakland, California; Department of Ophthalmology, University of California, San Francisco, San Francisco, California.

Nicola G Ghazi (NG)

Department of Ophthalmology, Gilbert and Rose-Marie Chagoury School of Medicine, The Lebanese American University and the Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.

Prithvi Ramtohul (P)

Centre Hospitalier Universitaire de l'Hôpital Nord, Marseille, France.

Jennifer J Arnold (JJ)

Marsden Eye Specialists, Parramatta, Australia.

Yoichi Sakurada (Y)

Vitreous Retina Macula Consultants of New York, New York, New York; Department of Ophthalmology, NYU School of Medicine, New York, New York; Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Netan Choudhry (N)

Vitreous Retina Macula Specialists of Toronto, Etobicoke, Canada.

Chandrakumar Balaratnasingam (C)

Lions Eye Institute, University of Western Australia, Perth, Australia; Department of Ophthalmology, Sir Charles Gairdner Hospital, Perth, Australia.

K Bailey Freund (KB)

Vitreous Retina Macula Consultants of New York, New York, New York; Department of Ophthalmology, NYU School of Medicine, New York, New York.

Carol L Shields (CL)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH